Vor Biopharma, Inc. (VOR)
13.55
+0.24
(+1.80%)
USD |
NASDAQ |
Feb 20, 16:00
13.56
+0.01
(+0.07%)
After-Hours: 20:00
Vor Biopharma Total Liabilities (Quarterly) : 2.402B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| iBio, Inc. | 7.833M |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| Senti Biosciences, Inc. | 44.56M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.24M |
| Shareholders Equity (Quarterly) | -2.225B |
| Debt to Equity Ratio | -0.0014 |
| Current Ratio | 9.156 |
| Net Debt Paydown Yield | 1.85% |